Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2011
Number of items: 22.

2022

Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P., Schorb, Elisabeth, Celico, Claudia, Falautano, Monica, Nonis, Alessandro, La Rosee, Paul ORCID: 0000-0002-6758-7809, Binder, Mascia, Fabbri, Alberto, Ilariucci, Fiorella, Krampera, Mauro, Roth, Alexander, Hemmaway, Claire, Johnson, Peter W., Linton, Kim M., Pukrop, Tobias, Gorlov, Jettes Sonderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jense, Tucci, Alessandra, Orsucci, Lorella, Pisani, Francesco, Zanni, Manuela, Krause, Stefan W., Schmoll, Hans J., Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Thurner, Lorenz, Cabras, Giuseppina, Pennese, Elsa, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Jurgen, Ferranti, Antonella, Cozens, Kelly, Burger, Elvira, Ielmini, Nicoletta, Cavalli, Franco, Zucca, Emanuele and Illerhaus, Gerald (2022). Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial. Leukemia, 36 (7). S. 1870 - 1879. LONDON: SPRINGERNATURE. ISSN 1476-5551

Illerhaus, Gerald, Farreri, Andres J. M., Binder, Mascha, Borchmann, Peter, Hasenkamp, Justin, Stilgenbauer, Stephan, Roeth, Alexander, Webern, Thomas, Egerer, Gerlinde, Ernst, Thomas, Hertenstein, Bernd, Lenz, Georg, Kobbe, Guido, Brunnberg, Uta, Schmidt, Christian, Kneba, Michael, Dreyling, Martin, Moehle, Robert, Panse, Jens, Heinicke, Thomas, Schroll, Sebastian, Larsen, Thomas S., Salwender, Hans, Naumann, Ralph, Hess, Georg, Thurner, Lorenz, Pukrop, Tobias, Keller, Ulrich, Blystadt, Anne Kirsti, Kroschinsky, Frank P., Re, Francesca, Pulczynski, Elisa, Orsucci, Lorella, Pospiech, Lisa, Deckert, Martina, Ponzoni, Maurilio, Wendler, Julia, Valk, Elke, Calimeri, Teresa, Kasenda, Benjamin, Trepel, Martin, Fricker, Heidi, von Gottberg, Philipp, Burger, Elvira, Ihorst, Gabriele, Grishina, Olga, Hader, Claudia, Zucca, Emanuele, Finke, Juergen and Schorb, Elisabeth (2022). Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43). Blood, 140. S. 10 - 14. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stroh, Jacob, Seckinger, Anja, Heider, Michael, Rudelius, Martina, Eichner, Ruth ORCID: 0000-0002-8433-9452, Schick, Markus, Slawska, Jolanta, Emde-Rajaratnam, Martina, Salwender, Hans, Bertsch, Uta, Goldschmidt, Hartmut, Weisel, Katja, Scheid, Christof, Keller, Ulrich, Hose, Dirk and Bassermann, Florian (2022). MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma. Blood Adv., 6 (2). S. 515 - 521. AMSTERDAM: ELSEVIER. ISSN 2473-9537

2021

Liebers, Nora, Duell, Johannes, Fitzgerald, Donnacha ORCID: 0000-0003-4927-7484, Kerkhoff, Andrea, Noerenberg, Daniel, Kaebisch, Eva ORCID: 0000-0001-7752-4126, Acker, Fabian ORCID: 0000-0002-6207-0237, Fuhrmann, Stephan ORCID: 0000-0002-7785-2565, Leng, Corinna, Welslau, Manfred, Chemnitz, Jens, Middeke, Jan-Moritz, Weber, Thomas, Holtick, Udo, Trappe, Ralf, Pfannes, Roald, Liersch, Ruediger, Spoer, Christian, Fuxius, Stefan, Gebauer, Niklas, Caille, Leandra, Geer, Thomas, Koenecke, Christian, Keller, Ulrich, Claus, Rainer, Mougiakakos, Dimitrios, Mayer, Stephanie, Huettmann, Andreas, Pott, Christiane, Trummer, Arne, Wulf, Gerald, Brunnberg, Uta, Bullinger, Lars ORCID: 0000-0002-5890-5510, Hess, Georg, Mueller-Tidow, Carsten, Glass, Bertram, Lenz, Georg, Dreger, Peter and Dietrich, Sascha (2021). Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas. Blood Adv., 5 (13). S. 2707 - 2717. AMSTERDAM: ELSEVIER. ISSN 2473-9537

Obenaus, Matthias, Schildgen, Oliver ORCID: 0000-0003-4297-9627, Schuermann, Dirk, von Bruenneck, Ann-Christin, Janz, Martin ORCID: 0000-0002-1127-0044, Keller, Ulrich, Gebauer, Bernhard, Schilling, Johannes, Schwartz, Stefan ORCID: 0000-0001-8833-5793, Weissbrich, Benedikt, Schneider, Thomas ORCID: 0000-0003-1125-0518, Hofmann, Joerg and Mathas, Stephan (2021). High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery. ERJ Open Res., 7 (2). SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 2312-0541

Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Mettler, Jasmin, van Heek, Lutz, Goergen, Helen, Mueller, Horst, Baues, Christian, Keller, Ulrich, Meissner, Julia, Trautmann-Grill, Karolin, Kerkhoff, Andrea, Fuchs, Michael, Sasse, Stephanie, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter, Engert, Andreas, Kobe, Carsten and Broeckelmann, Paul J. (2021). Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial. Clin. Cancer Res., 27 (2). S. 402 - 408. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

2020

Broeckelmann, Paul J., Goergen, Helen, Keller, Ulrich, Meissner, Julia, Ordemann, Rainer, Halbsguth, Teresa V., Sasse, Stephanie, Soekler, Martin, Kerkhoff, Andrea, Mathas, Stephan, Huettmann, Andreas, Bormann, Matthias, Zimmermann, Andreas, Mettler, Jasmin, Fuchs, Michael, von Tresckow, Bastian, Baues, Christian, Rosenwald, Andreas, Klapper, Wolfram, Kobe, Carsten, Borchmann, Peter and Engert, Andreas (2020). Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial. JAMA Oncol., 6 (6). S. 872 - 881. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445

Herhaus, Peter, Lipkova, Jana, Lammer, Felicitas, Yakushev, Igor, Vag, Tibor, Slotta-Huspenina, Julia, Habringer, Stefan, Lapa, Constantin, Pukrop, Tobias, Hellwig, Dirk, Wiestler, Benedikt ORCID: 0000-0002-2963-7772, Buck, Andreas K., Deckert, Martina, Wester, Hans-Juergen, Bassermann, Florian, Schwaiger, Markus, Weber, Wolfgang, Menze, Bjoern and Keller, Ulrich (2020). CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma. J. Nucl. Med., 61 (12). RESTON: SOC NUCLEAR MEDICINE INC. ISSN 1535-5667

Hess, Georg, Wagner, Karola, Keller, Ulrich, La Rosee, Paul, Atta, Johannes, Huebel, Kai, Lerchenmueller, Christian, Schoendube, Daniel, Witzens-Harig, Mathias, Ruckes, Christian, Medler, Christoph, van Oordt, Christina, Klapper, Wolfram, Theobald, Matthias and Dreyling, Martin (2020). Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma. Hemasphere, 4 (3). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Reinke, Sarah, Broeckelmann, Paul J., Iaccarino, Ingram, Garcia-Marquez, Maria, Borchmann, Sven, Jochims, Franziska, Kotrova, Michaela ORCID: 0000-0001-5394-1072, Pal, Karol, Brueggemann, Monika, Hartmann, Elena, Sasse, Stephanie, Kobe, Carsten, Mathas, Stephan, Soekler, Martin, Keller, Ulrich, Bormann, Matthias, Zimmermann, Andreas, Richter, Julia, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Schloesser, Hans, von Bergwelt-Baildon, Michael, Rosenwald, Andreas, Engert, Andreas and Klapper, Wolfram (2020). Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1. Blood, 136 (25). S. 2851 - 2864. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2019

Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Borchmann, Peter, Viardot, Andreas, Soekler, Martin, Keller, Ulrich, Schmidt, Christian, Truemper, Lorenz, Mahlberg, Rolf, Marks, Reinhard, Hoeffkes, Heinz-Gert, Metzner, Bernd, Dierlamm, Judith, Frickhofen, Norbert, Haenel, Mathias, Neubauer, Andreas, Kneba, Michael, Merli, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Brown, Peter de Nully ORCID: 0000-0002-6522-4086, Federico, Massimo, Lengfelder, Eva, di Rocco, Alice, Trappe, Ralf ORCID: 0000-0001-7565-7160, Rosenwald, Andreas, Berdel, Christian, Maisenhoelder, Martin, Shpilberg, Ofer, Amam, Josif, Christofyllakis, Konstantinos ORCID: 0000-0002-0308-388X, Hartmann, Frank, Murawski, Niels, Stilgenbauer, Stephan, Nickelsen, Maike, Wulf, Gerald, Glass, Bertram, Schmitz, Norbert, Altmann, Bettina, Loeffler, Markus and Pfreundschuh, Michael (2019). Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Lancet, 394 (10216). S. 2271 - 2282. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

2018

Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Altmann, Bettina, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Viardot, Andreas, Borchmann, Peter, Kanz, Lothar, Keller, Ulrich, Schmidt, Christian, Mahlberg, Rolf, Metzner, Bernd, Marks, Reinhard, Hoeffkes, Heinz-Gert, Christofyllakis, Konstantinos, Amam, Josif, Berdel, Christian, Stilgenbauer, Stephan, Schmitz, Norbert, Truemper, Lorenz, Murawski, Niels, Loeffler, Markus and Pfreundschuh, Michael (2018). Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2017

Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Lohri, Andreas, Mey, Ulrich, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Ostermann, Helmut, Keller, Ulrich, Maschmeyer, Georg, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2017). Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group. Lancet Oncol., 18 (4). S. 454 - 464. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P., Schorb, Elisabeth, La Rosee, Paul, Binder, Mascha ORCID: 0000-0003-0663-3004, Fabbri, Alberto, Torri, Valter ORCID: 0000-0001-9541-9354, Minacapelli, Eleonora, Falautano, Monica, Ilariucci, Fiorella, Ambrosetti, Achille, Roth, Alexander, Hemmaway, Claire, Johnson, Peter ORCID: 0000-0003-2306-4974, Linton, Kim M., Pukrop, Tobias, Gorlov, Jette Sonderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jens, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Orsucci, Lorella, Pisani, Francesco, Levis, Alessandro, Krause, Stefan W., Schmoll, Hans J., Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Pfreundschuh, Michael, Cabras, Giuseppina, Angrilli, Francesco, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Juergen, Reni, Michele, Cavalli, Franco, Zucca, Emanuele ORCID: 0000-0002-5522-6109 and Illerhaus, Gerald (2017). Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. Lancet Haematol., 4 (11). S. E510 - 14. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

2016

Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elisa Jacobsen, Fox, Christopher P., Schorb, Elisabeth, La Rosee, Paul, Binder, Mascha, Fabbri, Alberto, Torri, Valter ORCID: 0000-0001-9541-9354, Minacapelli, Eleonora, Falautano, Monica, Ilariucci, Fiorella, Ambrosetti, Achille, Roth, Alexander, Hemmaway, Claire Jane, Johnson, Peter M., Linton, Kim, Pukrop, Tobias, Gorlov, Jette Sonderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jens P., Tucci, Alessandra, Orsucci, Lorella, Pisani, Francesco, Levis, Alessandro, Krause, Stefan W., Schmoll, Hans-Joachim, Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Pfreundschuh, Michael, Cabras, Giuseppina, Angrilli, Francesco, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Jurgen, Reni, Michele, Cavalli, Franco, Zucca, Emanuele and Illerhaus, Gerald (2016). Effects on Survival and Neurocognitive Functions of Whole-Brain Radiotherapy (WBRT) and Autologous Stem Cell Transplantation (ASCT) as Consolidation Options after High-Dose Methotrexate-Based Chemoimmunotherapy in Patients with Newly Diagnosed Primary CNS Lymphoma (PCNSL): Results of the Second Randomization of the IELSG32 Trial. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elko, Ponzoni, Mourilio, Deckert, Martina, Politi, Letterio S., Torri, Valter ORCID: 0000-0001-9541-9354, Fox, Christopher P., La Rosee, Paul ORCID: 0000-0002-6758-7809, Schorb, Elisabeth, Ambrosetti, Achille, Roth, Alexander, Hemmoway, Claire, Ferrari, Angela ORCID: 0000-0002-9984-1146, Linton, Kim M., Ruda, Roberta, Binder, Mascha ORCID: 0000-0003-0663-3004, Pukrop, Tobias, Balzarotti, Monica, Fabbri, Alberto, Johnson, Peter, Gorlov, Jette Sonderskov, Hess, Georg, Panse, Jens, Pisani, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Stilgenbauer, Stephan, Hertenstein, Bernd, Keller, Ulrich, Krause, Stefan W., Levis, Alessandro, Schmoll, Hans J., Covalli, Franco, Finke, Jurgen, Reni, Michele ORCID: 0000-0002-6463-0293, Zucca, Emanuele ORCID: 0000-0002-5522-6109 and Illerhaus, Gerald (2016). Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol., 3 (5). S. E217 - 11. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

Hess, Georg, Karola, Wagner, LaRosee, Paul, Keller, Ulrich, Atta, Johannes, Witzens-Harig, Mathias, Crombe, Anne, Medler, Christoph, Borchmann, Peter, Bitz, Ulrich, Lerchenmuller, Christian, Theobald, Matthias and Dreyling, Martin H. (2016). Temsirolimus in Combination with Bendamustine and Rituximab (BeRT) for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Final Phase I/II Results. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Illerhaus, Gerald, Kasenda, Benjamin ORCID: 0000-0003-0110-8585, Ihorst, Gabriele, Egerer, Gerlinde, Lamprecht, Monika, Keller, Ulrich, Wolf, Hans-Heinrich, Hirt, Carsten, Stilgenbauer, Stephan, Binder, Mascha ORCID: 0000-0003-0663-3004, Hau, Peter ORCID: 0000-0003-3894-5053, Edinger, Matthias ORCID: 0000-0003-2889-2533, Frickhofen, Norbert, Bentz, Martin, Moehle, Robert, Roeth, Alexander, Pfreundschuh, Michael, von Baumgarten, Louisa, Deckert, Martina, Hader, Claudia, Fricker, Heidi, Valk, Elke, Schorb, Elisabeth, Fritsch, Kristina and Finke, Juergen (2016). High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. Lancet Haematol., 3 (8). S. E388 - 10. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

2015

Hess, Georg, Keller, Ulrich, Atta, Johannes, Bitz, Ulrich, Lerchenmueller, Christian, Karola, Wagner, Medler, Christoph, Ruckes, Christian, Witzens-Harig, Mathias, Huebel, Kai, LaRosee, Paul and Dreyling, Martin H. (2015). Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on an Ongoing Phase I/II Trial. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2014

Borchmann, Peter, Haverkamp, Heinz, Lohri, Andreas, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Engel, Nicole, Keller, Ulrich, Maschmeyer, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2014). Addition of Rituximab to BEACOPP(escalated) to Improve the Outcome of Early Interim PET Positive Advanced Stage Hodgkin Lymphoma Patients: Second Planned Interim Analysis of the HD18 Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Pfreundschuh, Michael, Poeschel, Viola, Zeynalova, Samira, Haenel, Mathias, Held, Gerhard, Schmitz, Norbert, Viardot, Andreas, Dreyling, Martin H., Hallek, Michael, Mueller, Carsten, Wiesen, Martin H. J., Witzens-Harig, Mathias ORCID: 0000-0002-2799-4661, Truemper, Lorenz, Keller, Ulrich, Rixecker, Tanja, Zwick, Carsten and Murawski, Niels (2014). Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group. J. Clin. Oncol., 32 (36). S. 4127 - 4135. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

2011

Boell, Boris, Bredenfeld, Henning, Goergen, Helen, Halbsguth, Teresa, Eich, Hans T., Soekler, Martin, Markova, Jana, Keller, Ulrich, Graeven, Ullrich, Kremers, Stephan, Geissler, Michael, Trenn, Guido, Fuchs, Michael, von Tresckow, Bastian, Eichenauer, Dennis A., Borchmann, Peter and Engert, Andreas (2011). Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma. Blood, 118 (24). S. 6292 - 6299. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Fri Apr 19 21:04:05 2024 CEST.